Walleye Trading’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,900
Closed -$135K 5506
2022
Q3
$135K Hold
2,900
﹤0.01% 3935
2022
Q2
$127K Sell
2,900
-100
-3% -$5.5K ﹤0.01% 4017
2022
Q1
$217K Buy
3,000
+1,000
+50% +$72.1K ﹤0.01% 3721
2021
Q4
$162K Buy
+2,000
New +$200K ﹤0.01% 4065
2021
Q3
Sell
-1,800
Closed -$298K 5817
2021
Q2
$298K Buy
1,800
+300
+20% +$46.8K ﹤0.01% 3507
2021
Q1
$209K Buy
+1,500
New +$245K ﹤0.01% 3569
2020
Q4
Sell
-100
Closed -$14K 5006
2020
Q3
$14K Buy
+100
New +$13.4K ﹤0.01% 3876
2020
Q2
Sell
-1,600
Closed -$160K 4685
2020
Q1
$160K Buy
+1,600
New +$192K ﹤0.01% 2800
2019
Q4
Sell
-18,100
Closed -$1.56M 4706
2019
Q3
$1.56M Sell
18,100
-2,100
-10% -$159K 0.01% 1252
2019
Q2
$1.31M Buy
20,200
+800
+4% +$49.8K 0.01% 1382
2019
Q1
$1.21M Buy
+19,400
New +$912K 0.01% 1485
2018
Q4
Sell
-9,500
Closed -$542K 5431
2018
Q3
$542K Sell
9,500
-100
-1% -$6.25K ﹤0.01% 2808
2018
Q2
$767K Buy
9,600
+8,100
+540% +$672K ﹤0.01% 2389
2018
Q1
$130K Buy
+1,500
New +$121K ﹤0.01% 3770
2017
Q4
Sell
-1,000
Closed -$91 4704
2017
Q3
$91 Buy
+1,000
New +$85.6K ﹤0.01% 3641

Other funds holding NVRO

Walleye Trading's NVRO Position: Q2 2025 in Review

Walleye Trading sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 14,599 shares — an estimated $85.3K sold.

Walleye Trading first reported a position in NVRO in Q3 2017 and held it in 13 quarters. The position peaked at $1.29M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Walleye Trading reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 14,599 NEVRO CORP. shares in Q2 2025, an estimated $85.3K.
  • Walleye Trading first reported a position in NEVRO CORP. in Q3 2017 and held it in 13 quarters.
  • Walleye Trading's NEVRO CORP. position peaked at $1.29M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.